HIGHLIGHTS
- who: Rick Heida and colleagues from the Department of Pharmaceutical Technology and Biopharmacy, University of Groningen have published the paper: Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro, in the Journal: Pharmaceuticals 2022, 887 of /2022/
- what: The authors made use of influenza subunits (hereafter referred to as influenza antigens) and hepatitis B surface antigen (HBsAg) and conjugated them covalently to either polystyrene nanoparticles of 500 nm or microparticles of 3 u00b5m to increase their size. Especially in the context of a multi . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.